1. Home
  2. GOSS vs PANL Comparison

GOSS vs PANL Comparison

Compare GOSS & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • PANL
  • Stock Information
  • Founded
  • GOSS 2015
  • PANL 1996
  • Country
  • GOSS United States
  • PANL United States
  • Employees
  • GOSS N/A
  • PANL N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • GOSS Health Care
  • PANL Consumer Discretionary
  • Exchange
  • GOSS Nasdaq
  • PANL Nasdaq
  • Market Cap
  • GOSS 347.8M
  • PANL 328.2M
  • IPO Year
  • GOSS 2019
  • PANL N/A
  • Fundamental
  • Price
  • GOSS $2.47
  • PANL $5.33
  • Analyst Decision
  • GOSS Strong Buy
  • PANL Strong Buy
  • Analyst Count
  • GOSS 4
  • PANL 1
  • Target Price
  • GOSS $8.50
  • PANL $9.00
  • AVG Volume (30 Days)
  • GOSS 3.1M
  • PANL 222.3K
  • Earning Date
  • GOSS 08-05-2025
  • PANL 08-07-2025
  • Dividend Yield
  • GOSS N/A
  • PANL 3.75%
  • EPS Growth
  • GOSS N/A
  • PANL N/A
  • EPS
  • GOSS N/A
  • PANL 0.16
  • Revenue
  • GOSS $40,237,000.00
  • PANL $579,781,169.00
  • Revenue This Year
  • GOSS N/A
  • PANL $13.00
  • Revenue Next Year
  • GOSS $30.65
  • PANL N/A
  • P/E Ratio
  • GOSS N/A
  • PANL $33.08
  • Revenue Growth
  • GOSS N/A
  • PANL 15.10
  • 52 Week Low
  • GOSS $0.66
  • PANL $3.93
  • 52 Week High
  • GOSS $2.65
  • PANL $7.50
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 68.08
  • PANL 59.78
  • Support Level
  • GOSS $2.38
  • PANL $5.21
  • Resistance Level
  • GOSS $2.65
  • PANL $5.48
  • Average True Range (ATR)
  • GOSS 0.15
  • PANL 0.16
  • MACD
  • GOSS 0.03
  • PANL 0.03
  • Stochastic Oscillator
  • GOSS 76.67
  • PANL 75.81

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: